{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:01:36Z","timestamp":1790413296641,"version":"4.1.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,23]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The use of mature neutrophil (granulocyte) transfusions for the treatment of neutropenic patients with invasive fungal infections (IFIs) has been the focus of multiple clinical trials. Despite these efforts, the transfusion of mature neutrophils has resulted in limited clinical benefit, likely owing to problems of insufficient numbers and the very short lifespan of these donor cells. In this report, we employed a system of conditionally immortalized murine neutrophil progenitors that are capable of continuous expansion, allowing for the generation of unlimited numbers of homogenous granulocyte-macrophage progenitors (GMPs). These GMPs were assayed in vivo to demonstrate their effect on survival in 2 models of IFI: candidemia and pulmonary aspergillosis. Mature neutrophils derived from GMPs executed all cardinal functions of neutrophils. Transfused GMPs homed to the bone marrow and spleen, where they completed normal differentiation to mature neutrophils. These neutrophils were capable of homing and extravasation in response to inflammatory stimuli using a sterile peritoneal challenge model. Furthermore, conditionally immortalized GMP transfusions significantly improved survival in models of candidemia and pulmonary aspergillosis. These data confirm the therapeutic benefit of prophylactic GMP transfusions in the setting of neutropenia and encourage development of progenitor cellular therapies for the management of fungal disease in high-risk patients.<\/jats:p>","DOI":"10.1002\/jlb.4hi1221-722r","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T08:38:02Z","timestamp":1648715882000},"page":"1133-1145","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Transfusable neutrophil progenitors as cellular therapy for the prevention of invasive fungal infections"],"prefix":"10.1093","volume":"111","author":[{"given":"David B","family":"Sykes","sequence":"first","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Center for Regenerative Medicine , Boston, Massachusetts, USA"},{"name":"Harvard Stem Cell Institute , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M","family":"Martinelli","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Center for Regenerative Medicine , Boston, Massachusetts, USA"},{"name":"Harvard Stem Cell Institute , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Negoro","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Maxcy","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Center for Regenerative Medicine , Boston, Massachusetts, USA"},{"name":"Harvard Stem Cell Institute , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Timmer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L","family":"Viens","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J","family":"Alexander","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0681-9087","authenticated-orcid":false,"given":"Johnny","family":"Atallah","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan D","family":"Snarr","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Center , Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane R","family":"Baistrocchi","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Center , Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J","family":"Atallah","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hopke","sequence":"additional","affiliation":[{"name":"BioMEMS, Massachusetts General Hospital , Boston, Massachusetts, USA"},{"name":"Department of Surgery, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Scherer","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Rosales","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Irimia","sequence":"additional","affiliation":[{"name":"BioMEMS, Massachusetts General Hospital , Boston, Massachusetts, USA"},{"name":"Department of Surgery, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C","family":"Sheppard","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Center , Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8892-8695","authenticated-orcid":false,"given":"Michael K","family":"Mansour","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts, USA"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"2023032109025083400_","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00471","article-title":"How neutrophils shape adaptive immune responses","volume":"6","author":"Leliefeld","year":"2015","journal-title":"Front Immunol"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ng1940","article-title":"HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)","volume":"39","author":"Klein","year":"2007","journal-title":"Nat Genet"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0140-6736(02)11201-3","article-title":"Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study","volume":"360","author":"P\u00fctsep","year":"2002","journal-title":"Lancet"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"Jama"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006290","article-title":"Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally","volume":"13","author":"Chowdhary","year":"2017","journal-title":"PLoS Pathog"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40168-017-0373-4","article-title":"The gut mycobiome of the Human Microbiome Project healthy cohort","volume":"5","author":"Nash","year":"2017","journal-title":"Microbiome"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"Denning","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1086\/374894","article-title":"Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia","volume":"36","author":"Myoken","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3109\/13693786.2010.505204","article-title":"Clinical risk factors for invasive aspergillosis","volume":"49","author":"Baddley","year":"2011","journal-title":"Med Mycol"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial Bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jinf.2005.04.020","article-title":"Risk factors and outcome for nosocomial breakthrough candidaemia","volume":"52","author":"Pasqualotto","year":"2006","journal-title":"J Infection"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0040035","article-title":"Mucosal damage and neutropenia are required for Candida albicans dissemination","volume":"4","author":"Koh","year":"2008","journal-title":"PLoS Pathog"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1128\/AAC.02533-12","article-title":"Experimental evidence that granulocyte transfusions are efficacious in treatment of neutropenic hosts with pulmonary Aspergillosis","volume":"57","author":"Martinez","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/j.1537-2995.2006.00996.x","article-title":"Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections","volume":"46","author":"Sachs","year":"2006","journal-title":"Transfusion"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1537-2995.1999.39090983.x","article-title":"Granulocyte storage and antigen stability","volume":"39","author":"Chun","year":"1999","journal-title":"Transfusion"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12967-015-0724-5","article-title":"Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies","volume":"13","author":"Cugno","year":"2015","journal-title":"J Transl Med"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.20.01739","article-title":"Open-label phase II prospective, randomized, controlled study of romyelocel-L myeloid progenitor cells to reduce infection during induction chemotherapy for acute myeloid leukemia","volume":"39","author":"Desai","year":"2021","journal-title":"J Clin Oncol"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM197208242870801","article-title":"Normal granulocyte transfusion therapy \u2014 treatment of septicemia due to gram-negative bacteria","volume":"287","author":"Graw","year":"1972","journal-title":"New Engl J Med"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0192-0561(87)90042-7","article-title":"Melphalan-induced appearance of potent antitumor immune reactivity in tumor bearer lymphocytes co-expressing the lyt 2 and the L3T4 antigens","volume":"9","author":"Takesue","year":"1987","journal-title":"Int J Immunopharmacol"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0002-9343(77)90200-5","article-title":"A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia","volume":"63","author":"Vogler","year":"1977","journal-title":"Am J Med"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM197504102921501","article-title":"Filtration leukapheresis for granulocyte transfusion therapy \u2014 clinical and laboratory studies","volume":"292","author":"Higby","year":"1975","journal-title":"New Engl J Medicine"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2017.02.026","article-title":"Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience","volume":"140","author":"Marciano","year":"2017","journal-title":"J Allergy Clin Immun"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM197805112981904","article-title":"Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants","volume":"298","author":"Clift","year":"1978","journal-title":"New Engl J Med"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1537-2995.1975.15676082229.x","article-title":"Granulocyte transfusion: a controlled study in patients with acute nonlymphocytic leukemia","volume":"15","author":"Fortuny","year":"1975","journal-title":"Transfusion"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-97-4-509","article-title":"Therapeutic granulocyte transfusions for documented infections: a controlled trial in ninety-five infectious granulocytopenic episodes","volume":"97","author":"Winston","year":"1982","journal-title":"Ann Intern Med"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone\u2013treated donors in neutropenic patients with infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1537-2995.2001.41081037.x","article-title":"Administration of G\u2013CSF plus dexamethasone producesgreater granulocyte concentrate yields while causing nomore donor toxicity than G\u2013CSF alone","volume":"41","author":"Stroncek","year":"2001","journal-title":"Transfusion"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2016-03-700336","article-title":"Human neutrophil kinetics: modeling of stable isotope labeling data supports short blood neutrophil half-lives","volume":"127","author":"Lahoz-Beneytez","year":"2016","journal-title":"Blood"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1537-2995.1979.19179160266.x","article-title":"Characteristics of stored granulocytes collected from donors stimulated with dexamethasone","volume":"19","author":"Glasser","year":"1979","journal-title":"Transfusion"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2019.00021","article-title":"Ex vivo manufactured neutrophils for treatment of neutropenia\u2014a process economic evaluation","volume":"6","author":"Torres-Acosta","year":"2019","journal-title":"Front Med"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/bit.22433","article-title":"Clinical scale ex vivo manufacture of neutrophils from hematopoietic progenitor cells","volume":"104","author":"Timmins","year":"2009","journal-title":"Biotechnol Bioeng"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nmeth865","article-title":"Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8","volume":"3","author":"Wang","year":"2006","journal-title":"Nat Methods"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2002-05-1552","article-title":"Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation","volume":"100","author":"BitMansour","year":"2002","journal-title":"Blood"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1182\/blood-2004-07-2676","article-title":"Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia","volume":"105","author":"BitMansour","year":"2004","journal-title":"Blood"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1086\/491743","article-title":"Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted","volume":"192","author":"Arber","year":"2005","journal-title":"J Infect Dis"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"12223","DOI":"10.1073\/pnas.91.25.12223","article-title":"Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells","volume":"91","author":"Sauvageau","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0092-8674(02)00697-9","article-title":"HOXB4-induced expansion of adult hematopoietic stem cells ex vivo","volume":"109","author":"Antonchuk","year":"2002","journal-title":"Cell"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/cimm.2001.1895","article-title":"Observation of antigen-dependent CD8+ T-cell\/dendritic cell interactions in vivo","volume":"214","author":"Schaefer","year":"2001","journal-title":"Cell Immunol"},{"key":"2023032109025083400_","first-page":"1260","article-title":"Mucosal candidiasis elicits NF-\u03baB activation, proinflammatory gene expression and localized neutrophilia in zebrafish","volume":"6","author":"Gratacap","year":"2013","journal-title":"Dis Model Mech"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.stemcr.2016.04.010","article-title":"Single targeted exon mutation creates a true congenic mouse for competitive hematopoietic stem cell transplantation: the C57BL\/6-CD45.1(STEM) mouse","volume":"6","author":"Mercier","year":"2016","journal-title":"Stem Cell Rep"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1186\/s13104-017-3019-5","article-title":"Selecting the right gate to identify relevant cells for your assay: a study of thioglycollate-elicited peritoneal exudate cells in mice","volume":"10","author":"Hermida","year":"2017","journal-title":"BMC Res Notes"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1136\/annrheumdis-2019-216108","article-title":"Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs","volume":"78","author":"Matei","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"e02043","DOI":"10.1128\/mBio.02043-19","article-title":"Spleen tyrosine kinase is a critical regulator of neutrophil responses to Candida species","volume":"11","author":"Negoro","year":"2020","journal-title":"Mbio"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/imr.12454","article-title":"How neutrophils kill fungi","volume":"273","author":"Gazendam","year":"2017","journal-title":"Immunol Rev"},{"key":"2023032109025083400_","first-page":"9.11.1","article-title":"Flow cytometric analysis of cell division by dilution of CFSE and related dyes","volume":"64","author":"Lyons","year":"2013","journal-title":"Curr Protoc Cytom"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000321157","article-title":"Organ-specific innate immune responses in a mouse model of invasive Candidiasis","volume":"3","author":"Lionakis","year":"2011","journal-title":"J Innate Immun"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008544","article-title":"Platelets are critical for survival and tissue integrity during murine pulmonary Aspergillus fumigatus infection","volume":"16","author":"Tischler","year":"2020","journal-title":"PLoS Pathog"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002145","article-title":"In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary Aspergillosis","volume":"7","author":"Grahl","year":"2011","journal-title":"PLoS Pathog"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004378","article-title":"Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infection","volume":"10","author":"Shepardson","year":"2014","journal-title":"PLoS Pathog"},{"key":"2023032109025083400_","first-page":"96","article-title":"Practical murine hematopathology: a comparative review and implications for research","volume":"65","author":"O'Connell","year":"2015","journal-title":"Comparative Med"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3324\/haematol.2015.136630","article-title":"Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: a role for granule components","volume":"101","author":"Gazendam","year":"2016","journal-title":"Haematologica"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/br.2014.393","article-title":"Mechanism underlying renal failure caused by pathogenic Candida albicans infection","volume":"3","author":"Jae-Chen","year":"2015","journal-title":"Biomed Rep"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0092-8674(00)80358-X","article-title":"Nonfilamentous C. albicans mutants are avirulent","volume":"90","author":"Lo","year":"1997","journal-title":"Cell"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1038\/s41598-020-60792-y","article-title":"Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation","volume":"10","author":"Hirayama","year":"2020","journal-title":"Sci Rep-UK"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1172\/JCI71307","article-title":"CX3CR1-dependent renal macrophage survival promotes Candida control and host survival","volume":"123","author":"Lionakis","year":"2013","journal-title":"J Clin Invest"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/iai.57.6.1800-1808.1989","article-title":"In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon","volume":"57","author":"Garner","year":"1989","journal-title":"Infect Immun"},{"key":"2023032109025083400_","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1099\/13500872-142-12-3487","article-title":"Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance","volume":"142","author":"Fulurija","year":"1996","journal-title":"Microbiology"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/JLB.4HI1221-722R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/JLB.4HI1221-722R","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/111\/6\/1133\/49466962\/jlb11116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/111\/6\/1133\/49466962\/jlb11116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T13:05:21Z","timestamp":1700399121000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/111\/6\/1133\/6885159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":60,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3,31]]},"published-print":{"date-parts":[[2022,5,23]]}},"URL":"https:\/\/doi.org\/10.1002\/jlb.4hi1221-722r","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6]]},"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"2021-12-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}